The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis. - Alten, Rieke; Burmester, Gerd R.; Matucci-Cerinic, Marco; Salmon, Jean-Hugues; Lopez-Romero, Pedro; Fakhouri, Walid; de la Torre, Inmaculada; Zaremba-Pechmann, Liliana; Holzkämper, Thorsten; Fautrel, Bruno (Rheumatology & Therapy, 2023)